reports
- Gary Brode
Moody's Ratings affirms J&J's Aaa ratings; stable outlook
Moody's Ratings (Moody's) affirmed the ratings of Johnson & Johnson ("J&J") including the Aaa long-term issuer rating, Aaa senior unsecured rating, (P)Aaa senior unsecured medium term note program rating and Prime-1 commercial paper rating. The outlook remains stable. This rating action follows th...
Johnson & Johnson: 1 director
A director at Johnson & Johnson sold 8,891 shares at 162.160USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- MarketLine Department
Saponia dd - Company Profile and SWOT Analysis
Summary Saponia dd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Saponia dd (Saponia) is a manufacturer of home care and personal hygiene products. The company’s product portfolio comprises dish detergents, laundry detergents, toothbrushes, baby care, hand cream, shaving ...
Moody's: New setback in J&J talc litigation raises uncertainty
Moody's Investors Service commented that the recent setback in Johnson & Johnson's (Aaa stable) efforts to resolve outstanding talc litigation is credit negative. A federal judge dismissed the bankruptcy filing by J&J's subsidiary LTL Management LLC (LTL). This process would significantly reduce the...
- VRS RESEARCH TEAM
JOHNSON & JOHNSON Flash Note
Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being.
Moody's: J&J's talc proposal involves substantial long-term payments a...
Moody's Investors Service commented that Johnson & Johnson's recent decision to refile its subsidiary bankruptcy case related to North American talc lawsuits is credit negative due to material cash outflows intended to resolve the litigation. At the same time, the finalization of this plan would con...
- Brian Moretta
- Mark Thomas
- Martin Hall
- Riccardo Bindi
Hardman & Co Monthly: April 2023
Feature article: 2022 Pharma Statistics - 8.7% growth – but worrying signs An efficient reporting system has seen all the listed multinational pharmaceutical companies announcing results for 2022, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of the global and US rankings of the top 20 drug companies for 2022. 2022 was characterised by 8.7% underlying growth, offset by a large forex impact (-12%), due to USD stren...
INCY INCYTE CORP
IPN IPSEN SA
NOVN NOVARTIS AG
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TEVA.N TEVA PHARMACEUTICAL INDUSTRIES LIMITED SPONSORED ADR
REGN REGENERON PHARMACEUTICALS INC.
LLY MERCK & CO. INC.
JNJ ELI LILLY AND COMPANY
J7Z JOHNSON & JOHNSON
HZNP JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
GILD HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
BMY GILEAD SCIENCES INC.
BIIB BRISTOL-MYERS SQUIBB COMPANY
FEV BIOGEN INC.
IBT FIDELITY EUROPEAN VALUES PLC
FCSS INTERNATIONAL BIOTECHNOLOGY TRUST PLC
FSV FIDELITY CHINA SPECIAL SITUATIONS PLC
FJV FIDELITY SPECIAL VALUES PLC
FAS FIDELITY JAPAN TRUST
AVO FIDELITY ASIAN VALUES PLC
CLIG ADVANCED ONCOTHERAPY
MRK CITY OF LONDON INVESTMENT GROUP
NOVO B MERCK KGAA
novob NOVO NORDISK A/S CLASS B
RECI NOVO NORDISK
SAN REAL ESTATE CREDIT INVESTMENTS
UCB SANOFI
HIK UCB S.A.
PIN HIKMA PHARMACEUTICALS PLC
PFIZER PANTHEON INTERNATIONAL
4506 PFIZER
4523 SUMITOMO DAINIPPON PHARMA CO. LTD.
4507 EISAI CO. LTD.
4568 SHIONOGI & CO. LTD.
VTAS DAIICHI SANKYO COMPANY LIMITED
STX VOLTA FINANCE (GBP)
4502 SHIELD THERAPEUTICS
HAT TAKEDA PHARMACEUTICAL CO. LTD.
OCI H&T GROUP
4578 OAKLEY CAPITAL INVESTMENTS
APAX OTSUKA HOLDINGS CO. LTD.
4503 APAX GLOBAL ALPHA
ICGT ASTELLAS PHARMA INC.
UTHR ICG ENTERPRISE TRUST
PFE UNITED THERAPEUTICS CORPORATION
AZN PFIZER INC.
GLAXO ASTRAZENECA PLC
ABBV GLAXOSMITHKLINE PHARMACEUTICALS
VRX CN ASTELLAS PHARMA INC
MRNA ABBVIE INC.
TXG BAUSCH HEALTH COMPANIES INC.
NOVO MODERNA INC.
VTRS 10X GENOMICS INC CLASS A
4568.T NOVO NORDISK A/S-B
ME VIATRIS INC.
OCL DAIICHI SANKYO COMPANY
LUND A LIMITED
23ANDME HLDG CO
OAKLEY CAPITAL
H. LUNDBECK A/S
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
WHR WHIRLPOOL CORPORATION
AMN AMN HEALTHCARE SERVICES INC.
WM WASTE MANAGEMENT INC.
TWI TITAN INTERNATIONAL INC.
PAYX PAYCHEX INC.
NDSN NORDSON CORPORATION
LLY ELI LILLY AND COMPANY
LIVN LIVANOVA PLC
KRNT KORNIT DIGITAL LTD.
KEYS KEYSIGHT TECHNOLOGIES INC
K KELLOGG COMPANY
JNJ JOHNSON & JOHNSON
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
HRL HORMEL FOODS CORPORATION
HAS HASBRO INC.
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
FARO FARO TECHNOLOGIES INC.
EPAM EPAM SYSTEMS INC.
CORT CORCEPT THERAPEUTICS INCORPORATED.
CALX CALIX NETWORKS
BAX BAXTER INTERNATIONAL INC.
AOSL ALPHA & OMEGA SEMICONDUCTOR
ADM ARCHER-DANIELS-MIDLAND COMPANY
SHW SHERWIN-WILLIAMS COMPANY
WMB WILLIAMS COMPANIES INC.
PFE PFIZER INC.
TTEC TTEC HOLDINGS INC.
INVA INNOVIVA INC.
TM. TOYOTA MOTOR CORP. (ADS)
KDP KEURIG DR PEPPER INC.
NIO NIO INC. SPONSORED ADR CLASS A
NLOK NORTONLIFELOCK INC.
TWST TWIST BIOSCIENCE
ITOS ITEOS THERAPEUTICS
BILL BILL.COM HOLDINGS
BEAM BEAM THERAPEUTICS
HRMY HARMONY BIOSCIENCES HOLDINGS
CTKB CYTEK BIOSCIENCES INC
EVA ENVIVA PARTNERS LP
- Thomas J. Schiessle
Cooperation with Janssen (J+J) ensures broader positioning - CFO chang...
FY22 should be able to meet FY22 guidance as milestone payments in Q4/22 (detail: 28.03.23) brought the necessary earnings improvement. Meanwhile, the underlying business (9M/22 underlying business: +27% YoY) continues to perform well. The specific J.POD® order intake - reportedly very encouraging - is to be watched closely, as from FY 23 onwards - with increasing margins in the course of the year - group profitability should benefit from it, thus fulfilling the "Action Plan 2025". The new CFO ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.